TY - JOUR AU - Chen, L. AU - Willis, S. N. AU - Wei, A. AU - Smith, B. J. AU - Fletcher, J. I. AU - Hinds, M. G. PY - 2005 DA - 2005// TI - Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function JO - Mol Cell VL - 17 UR - https://doi.org/10.1016/j.molcel.2004.12.030 DO - 10.1016/j.molcel.2004.12.030 ID - Chen2005 ER - TY - JOUR AU - Lam, L. T. AU - Zhang, H. AU - Chyla, B. PY - 2012 DA - 2012// TI - Biomarkers of therapeutic response to BCL2 antagonists in cancer JO - Mol Diagn Ther VL - 16 UR - https://doi.org/10.1007/s40291-012-0003-6 DO - 10.1007/s40291-012-0003-6 ID - Lam2012 ER - TY - JOUR AU - Bakhshi, A. AU - Jensen, J. P. AU - Goldman, P. AU - Wright, J. J. AU - McBride, O. W. AU - Epstein, A. L. PY - 1985 DA - 1985// TI - Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18 JO - Cell VL - 41 UR - https://doi.org/10.1016/S0092-8674(85)80070-2 DO - 10.1016/S0092-8674(85)80070-2 ID - Bakhshi1985 ER - TY - JOUR AU - Cleary, M. L. AU - Smith, S. D. AU - Sklar, J. PY - 1986 DA - 1986// TI - Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation JO - Cell VL - 47 UR - https://doi.org/10.1016/0092-8674(86)90362-4 DO - 10.1016/0092-8674(86)90362-4 ID - Cleary1986 ER - TY - JOUR AU - Tsujimoto, Y. AU - Cossman, J. AU - Jaffe, E. AU - Croce, C. M. PY - 1985 DA - 1985// TI - Involvement of the bcl-2 gene in human follicular lymphoma JO - Science VL - 228 UR - https://doi.org/10.1126/science.3874430 DO - 10.1126/science.3874430 ID - Tsujimoto1985 ER - TY - JOUR AU - Tsujimoto, Y. AU - Gorham, J. AU - Cossman, J. AU - Jaffe, E. AU - Croce, C. M. PY - 1985 DA - 1985// TI - The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining JO - Science VL - 229 UR - https://doi.org/10.1126/science.3929382 DO - 10.1126/science.3929382 ID - Tsujimoto1985 ER - TY - JOUR AU - Iqbal, J. AU - Sanger, W. G. AU - Horsman, D. E. AU - Rosenwald, A. AU - Pickering, D. L. AU - Dave, B. PY - 2004 DA - 2004// TI - BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma JO - Am J Pathol VL - 165 UR - https://doi.org/10.1016/S0002-9440(10)63284-1 DO - 10.1016/S0002-9440(10)63284-1 ID - Iqbal2004 ER - TY - JOUR AU - Leich, E. AU - Salaverria, I. AU - Bea, S. AU - Zettl, A. AU - Wright, G. AU - Moreno, V. PY - 2009 DA - 2009// TI - Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations JO - Blood VL - 114 UR - https://doi.org/10.1182/blood-2009-01-198580 DO - 10.1182/blood-2009-01-198580 ID - Leich2009 ER - TY - JOUR AU - Huang, J. Z. AU - Sanger, W. G. AU - Greiner, T. C. AU - Staudt, L. M. AU - Weisenburger, D. D. AU - Pickering, D. L. PY - 2002 DA - 2002// TI - The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile JO - Blood VL - 99 UR - https://doi.org/10.1182/blood.V99.7.2285 DO - 10.1182/blood.V99.7.2285 ID - Huang2002 ER - TY - JOUR AU - Iqbal, J. AU - Neppalli, V. T. AU - Wright, G. AU - Dave, B. J. AU - Horsman, D. E. AU - Rosenwald, A. PY - 2006 DA - 2006// TI - BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.4264 DO - 10.1200/JCO.2005.03.4264 ID - Iqbal2006 ER - TY - JOUR AU - Souers, A. J. AU - Leverson, J. D. AU - Boghaert, E. R. AU - Ackler, S. L. AU - Catron, N. D. AU - Chen, J. PY - 2013 DA - 2013// TI - ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3048 DO - 10.1038/nm.3048 ID - Souers2013 ER - TY - JOUR AU - Beroukhim, R. AU - Mermel, C. H. AU - Porter, D. AU - Wei, G. AU - Raychaudhuri, S. AU - Donovan, J. PY - 2010 DA - 2010// TI - The landscape of somatic copy-number alteration across human cancers JO - Nature VL - 463 UR - https://doi.org/10.1038/nature08822 DO - 10.1038/nature08822 ID - Beroukhim2010 ER - TY - JOUR AU - Zhang, H. AU - Guttikonda, S. AU - Roberts, L. AU - Uziel, T. AU - Semizarov, D. AU - Elmore, S. W. PY - 2011 DA - 2011// TI - Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2010.559 DO - 10.1038/onc.2010.559 ID - Zhang2011 ER - TY - JOUR AU - Cerami, E. AU - Gao, J. AU - Dogrusoz, U. AU - Gross, B. E. AU - Sumer, S. O. AU - Aksoy, B. A. PY - 2012 DA - 2012// TI - The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0095 DO - 10.1158/2159-8290.CD-12-0095 ID - Cerami2012 ER - TY - JOUR AU - Tao, Z. F. AU - Hasvold, L. AU - Wang, L. AU - Wang, X. AU - Petros, A. M. AU - Park, C. H. PY - 2014 DA - 2014// TI - Discovery of a potent and selective BCL-XL inhibitor with in vivo activity JO - ACS Med Chem Lett VL - 5 UR - https://doi.org/10.1021/ml5001867 DO - 10.1021/ml5001867 ID - Tao2014 ER - TY - JOUR AU - Tahir, S. K. AU - Yang, X. AU - Anderson, M. G. AU - Morgan-Lappe, S. E. AU - Sarthy, A. V. AU - Chen, J. PY - 2007 DA - 2007// TI - Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737 JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-2203 DO - 10.1158/0008-5472.CAN-06-2203 ID - Tahir2007 ER - TY - JOUR AU - Olejniczak, E. T. AU - Sant, C. AU - Anderson, M. G. AU - Wang, G. AU - Tahir, S. K. AU - Sauter, G. PY - 2007 DA - 2007// TI - Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains JO - Mol Cancer Res VL - 5 UR - https://doi.org/10.1158/1541-7786.MCR-06-0367 DO - 10.1158/1541-7786.MCR-06-0367 ID - Olejniczak2007 ER - TY - JOUR AU - Bodet, L. AU - Gomez-Bougie, P. AU - Touzeau, C. AU - Dousset, C. AU - Descamps, G. AU - Maiga, S. PY - 2011 DA - 2011// TI - ABT-737 is highly effective against molecular subgroups of multiple myeloma JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2010-11-317438 DO - 10.1182/blood-2010-11-317438 ID - Bodet2011 ER - TY - JOUR AU - Placzek, W. J. AU - Wei, J. AU - Kitada, S. AU - Zhai, D. AU - Reed, J. C. AU - Pellecchia, M. PY - 2010 DA - 2010// TI - A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy JO - Cell Death Dis VL - 1 UR - https://doi.org/10.1038/cddis.2010.18 DO - 10.1038/cddis.2010.18 ID - Placzek2010 ER - TY - JOUR AU - Basu, A. AU - Bodycombe, N. E. AU - Cheah, J. H. AU - Price, E. V. AU - Liu, K. AU - Schaefer, G. I. PY - 2013 DA - 2013// TI - An interactive resource to identify cancer genetic and lineage dependencies targeted by small molecules JO - Cell VL - 154 UR - https://doi.org/10.1016/j.cell.2013.08.003 DO - 10.1016/j.cell.2013.08.003 ID - Basu2013 ER - TY - JOUR AU - Rosenbluh, J. AU - Nijhawan, D. AU - Cox, A. G. AU - Li, X. AU - Neal, J. T. AU - Schafer, E. J. PY - 2012 DA - 2012// TI - beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis JO - Cell VL - 151 UR - https://doi.org/10.1016/j.cell.2012.11.026 DO - 10.1016/j.cell.2012.11.026 ID - Rosenbluh2012 ER - TY - JOUR AU - Neufeld, K. L. AU - Zhang, F. AU - Cullen, B. R. AU - White, R. L. PY - 2000 DA - 2000// TI - APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export JO - EMBO Rep VL - 1 UR - https://doi.org/10.1093/embo-reports/kvd117 DO - 10.1093/embo-reports/kvd117 ID - Neufeld2000 ER - TY - JOUR AU - Morin, P. J. AU - Sparks, A. B. AU - Korinek, V. AU - Barker, N. AU - Clevers, H. AU - Vogelstein, B. PY - 1997 DA - 1997// TI - Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC JO - Science VL - 275 UR - https://doi.org/10.1126/science.275.5307.1787 DO - 10.1126/science.275.5307.1787 ID - Morin1997 ER - TY - JOUR AU - Barretina, J. AU - Caponigro, G. AU - Stransky, N. AU - Venkatesan, K. AU - Margolin, A. A. AU - Kim, S. PY - 2012 DA - 2012// TI - The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity JO - Nature VL - 483 UR - https://doi.org/10.1038/nature11003 DO - 10.1038/nature11003 ID - Barretina2012 ER - TY - JOUR AU - Cory, S. AU - Huang, D. C. AU - Adams, J. M. PY - 2003 DA - 2003// TI - The Bcl-2 family: roles in cell survival and oncogenesis JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1207102 DO - 10.1038/sj.onc.1207102 ID - Cory2003 ER - TY - JOUR AU - Willis, S. N. AU - Chen, L. AU - Dewson, G. AU - Wei, A. AU - Naik, E. AU - Fletcher, J. I. PY - 2005 DA - 2005// TI - Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins JO - Genes Dev VL - 19 UR - https://doi.org/10.1101/gad.1304105 DO - 10.1101/gad.1304105 ID - Willis2005 ER - TY - JOUR AU - Chen, J. AU - Jin, S. AU - Abraham, V. AU - Huang, X. AU - Liu, B. AU - Mitten, M. J. PY - 2011 DA - 2011// TI - The Bcl-2/Bcl-XL/Bcl-w inhibitor, navitoclax, enhances the activity of chemotherapeutic agents in vitro and in vivo JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-11-0415 DO - 10.1158/1535-7163.MCT-11-0415 ID - Chen2011 ER - TY - JOUR AU - Lam, L. T. AU - Lu, X. AU - Zhang, H. AU - Lesniewski, R. AU - Rosenberg, S. AU - Semizarov, D. PY - 2010 DA - 2010// TI - A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax) JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-10-0427 DO - 10.1158/1535-7163.MCT-10-0427 ID - Lam2010 ER - TY - JOUR AU - Lam, L. T. AU - Roberts-Rapp, L. PY - 2014 DA - 2014// TI - Multiplex analysis of anti-apoptotic BCL2 family and caspase 3 activation by microbead arrays JO - Assay Drug Dev Technol VL - 12 UR - https://doi.org/10.1089/adt.2013.557 DO - 10.1089/adt.2013.557 ID - Lam2014 ER - TY - JOUR AU - Lin, X. AU - Morgan-Lappe, S. AU - Huang, X. AU - Li, L. AU - Zakula, D. M. AU - Vernetti, L. A. PY - 2007 DA - 2007// TI - ‘Seed’ analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737 JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210166 DO - 10.1038/sj.onc.1210166 ID - Lin2007 ER - TY - JOUR AU - Faber, A. C. AU - Coffee, E. M. AU - Costa, C. AU - Dastur, A. AU - Ebi, H. AU - Hata, A. N. PY - 2014 DA - 2014// TI - mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1 JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0315 DO - 10.1158/2159-8290.CD-13-0315 ID - Faber2014 ER - TY - JOUR AU - Lee, J. AU - Ou, S. H. PY - 2013 DA - 2013// TI - Towards the goal of personalized medicine in gastric cancer–time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway JO - Discov Med VL - 16 ID - Lee2013 ER -